S05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker: a comparison of blood pressure lowering - efficacy and safety

• Conditions: Essential arterial hypertension; MedDRA version: 14.0Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 10047065 - Vascular disorders; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2010-020945-28-BE
• Lead Sponsor: Institut de Recherches Internationales Servier

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-11-17
• Last Update Posted: 28 August 2014

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

- Outpatients,
- Men or women,
- 18 years old at least,
- Mild to moderate hypertensive patient.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1000
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 600

Exclusion Criteria

- Pregnant or breastfeeding women,
- Secondary hypertension,
- Any patient suffering from an acute or chronic illness.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified